Skip to main content
. 2017 May 2;88(18):1693–1700. doi: 10.1212/WNL.0000000000003886

Table 2.

Characteristics of participants with non–vitamin K antagonist oral anticoagulant (NOAC)–associated intracerebral hemorrhage (ICH) and vitamin K antagonist (VKA)–associated ICH

graphic file with name NEUROLOGY2016757070TT2.jpg